• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Diagn Pathol . Deadly Combination of Vaping-lnduced Lung Injury and Influenza: Case Report

tetano

Editor, Senior Moderator
Diagn Pathol


. 2020 Jul 9;15(1):83.
doi: 10.1186/s13000-020-00998-w.
Deadly Combination of Vaping-lnduced Lung Injury and Influenza: Case Report


Bindu H Akkanti[SUP] 1 [/SUP], Rahat Hussain[SUP] 1 [/SUP], Manish K Patel[SUP] 2 [/SUP], Jayeshkumar A Patel[SUP] 2 [/SUP], Kha Dinh[SUP] 1 [/SUP], Bihong Zhao[SUP] 3 [/SUP], Shaimaa Elzamly[SUP] 3 [/SUP], Kevin Pelicon[SUP] 2 [/SUP], Klemen Petek[SUP] 2 [/SUP], Ismael A Salas de Armas[SUP] 2 [/SUP], Mehmet Akay[SUP] 2 [/SUP], Biswajit Kar[SUP] 2 [/SUP], Igor D Gregoric[SUP] 2 [/SUP], L Maximilian Buja[SUP] 4 [/SUP]



Affiliations

Abstract

Background: E-cigarette and vaping use-associated acute lung injury (EVALI) has been recently recognized as a complication in individuals who use vaping devices. Another consideration is that EVALI may have an adverse influence on the outcome of intercurrent respiratory infections. We document this deadly combination in the case of a young man who had EVALI and simultaneous 41 Influenza-A infection leading to severe Acute Respiratory Distress Syndrome (ARDS).
Case presentation: A 27-year-old male with a history of tobacco and vaping use was admitted to hospital after two weeks of flu-like symptoms, diarrhea and vomiting. A chest x-ray was consistent with multifocal pneumonia, and microbiological tests were positive for Influenza-A and methicillin-sensitive Staphalacoccus aureus (MSSA). Bronchoscopy provided evidence of acute inhalational injury. After admission, he acutely decompensated with severe hypoxia and hypotension; he required intubation, sedation and vasopressors. He developed sepsis with acute kidney failure, liver failure, biventricular systolic dysfunction and severe rhabdomyolysis. He was placed on veno-venous (VV) extracorporeal membrane oxygenation (ECMO) initially and later changed to Veno-Arterial (VA) ECMO. Nevertheless, the patient continued to deteriorate, and he expired two weeks after admission.
Conclusion: This case documents that EVALI can act as a major factor leading a respiratory infection to progress into severe ARDS with a fatal outcome.

Keywords: Acute respiratory distress syndrome (ARDS); Case report; Diffuse alveolar damage (DAD); Influenza; Vaping.
 
Back
Top Bottom